Back

Meta-analysis of efficacy and safety of dual antiplatelet therapy versus aspirin monotherapy after coronary artery bypass grafting

European Journal of Preventive Cardiology

29 August 2020
Organised by: Logo
Read full article
ESC Journals

Contributors

Safi U Khan
Safi U Khan

Author

Guthrie Clinic Sayre , United States of America

Swapna Talluri
Swapna Talluri

Author

Hammad Rahman
Hammad Rahman

Author

Manidhar Lekkala
Manidhar Lekkala

Author

Muhammad S Khan
Muhammad S Khan

Author

Haris Riaz
Haris Riaz

Author

Harshil Shah
Harshil Shah

Author

Edo Kaluski
Edo Kaluski

Author

Sudhakar Sattur
Sudhakar Sattur

Author

You may be interested in
thumbnail
Congress Presentation
Perioperative aspirin and coronary artery bypass graft surgery: a meta-analysis of randomised controlled trials
25 August 2023
thumbnail
Congress Presentation
Thirty-days versus standard duration of dual antiplatelet treatment after percutaneous coronary interventions: a systematic review and meta-analysis
27 August 2022
thumbnail
Congress Presentation
Safety of dual antiplatelet pre-treatment in ACS patients undergoing unplanned aortocoronary bypass surgery
15 March 2025
thumbnail
Congress Presentation
Risk of myocardial infarction with coronary artery bypass grafting versus percutaneous coronary intervention: a systematic review and meta-analysis of fifteen randomised trials
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources